MedPath

Predictive Value of Dynamic Combination of BNP and NGAL for the Prognosis of Patients With Sepsis

Not Applicable
Completed
Conditions
28-day Mortality
Sepsis
Interventions
Other: BNP and NGAL
Registration Number
NCT02871544
Lead Sponsor
Southeast University, China
Brief Summary

Objective: to clarify the predictive value of brain natriuretic peptide (BNP) in combination with neutrophil gelatinase associated lipocalin (NGAL) for the prognosis of patients with sepsis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
124
Inclusion Criteria
  • age ≥18 years and <85 years;
  • presence of severe sepsis according to Survival Sepsis Campaign 10;
  • all patients voluntarily joined this study with informed consents.
Exclusion Criteria
  • participated in other trials within 30 days before the criteria for this trial were met;
  • expected to die within 24 hours;
  • pregnant;
  • advanced malignancy with life expectancy <6 months;
  • history of congestive heart failure;
  • chronic renal dysfunction (baseline creatinine >176.8μmol/L); and
  • relatives were unwilling to agree to the use of full life support.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Low BNP and High NGAL GroupBNP and NGALBNP≤100pg/ml and NGAL\>153pg/ml
Low BNP and Low NGAL GroupBNP and NGALBNP≤100pg/ml and NGAL≤153pg/ml
High BNP and Low NGAL GroupBNP and NGALBNP\>100pg/ml and NGAL≤153pg/ml
High BNP and High NGAL GroupBNP and NGALBNP\>100pg/ml and NGAL\>153pg/ml
Primary Outcome Measures
NameTimeMethod
patient-ventilator synchrony for 30mins30mins after the patients involved
Secondary Outcome Measures
NameTimeMethod
28-day mortality28 days after the patients involved
Mechanical ventilation duration between day 1 and day 28days of mechanical ventilation between day 1 and day 28
the numbers of days in the ICU between day 1 and day 28the numbers of days in the ICU until day 28
© Copyright 2025. All Rights Reserved by MedPath